chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 10 hours after administration pain and stiffness in Armpit area.   Minor ache at injection site on arm  I began massaging the armpit area during the night and it helped to diffuse the pain and is somewhat more tolerable this being the next day.
Tongue minor swelled for 30 mins. Throat minor swelling for 1 hour. Dizzy
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The reporter stated that on 25-JUN-2014 the patient was vaccinated with PROQUAD (Merck) (lot # H021358, expiration date: 29-MAY-2014, dose, units, anatomical location, route of administration were not reported). No adverse effect has been observed. This is one of several reports from the same reporter. Additional information has been requested,
Flu vaccine given 11/09/2001 about noon. Sunday AM rash left ear, spread to back of neck, right ear and back of right hand, itching, burning. Treatment: Benadryl by mouth, rash stopped spreading, still there.
pt recv vax 29APR97 & 30APR c/o congestion advised humidifier & nose gtts;s/s resp distress;3MAY & 4MAY seen in ER c/o congestion;6MAY infant in bed w/aprent;dad awakened to find pt not breathing;paramedics & CHP ER unable to resusitate;
chest is tight; Fever; Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (chest is tight), PYREXIA (Fever) and HEADACHE (Headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST DISCOMFORT (chest is tight), PYREXIA (Fever) and HEADACHE (Headache). At the time of the report, CHEST DISCOMFORT (chest is tight), PYREXIA (Fever) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.    Concomitant product use was not provided.  Treatment information was not provided.
This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Shaking problemsv / a twik) and CONFUSIONAL STATE (Confused) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (Shaking problemsv / a twik) and CONFUSIONAL STATE (Confused). At the time of the report, TREMOR (Shaking problemsv / a twik) and CONFUSIONAL STATE (Confused) outcome was unknown.            No concomitant medication provided. No treatment information provided.
Sore throat; Fatigue; Runny nose; Congestion; Headaches; Coughing; Pain in lungs when coughing; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old, male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 26Apr2021 at 17:00 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccination within 4 weeks prior to the COVID-19 vaccine. On 29Apr2021 at 12:00, the patient experienced sore throat, fatigue, followed by runny nose, congestion, headaches, coughing and pain in the lungs when coughing. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visits, and the emergency room/department or urgent care. Since the vaccination, the patient was not tested for COVID-19. The clinical outcome of the events sore throat, fatigue, runny nose, congestion, headaches, coughing and pain in lungs when coughing were resolving at the time of the report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
At 2:19 told RN at observation area face "feels blotchy", otherwise was fine, no other sx."never wore this mask before".  Taken to cot, sat down. Pulse ox applied. SPO2 98%. Pulse 70. No blotches on arms or legs, but red blotches on palms. Pt. stated they are usually red for a couple of months,  has RA, then will go back to normal. Red  bumps  observed on palms especially  below thumb area. Benadryl 25 mg p.o. at 1422. "My head's not itchy. I don't seem to have anything anywhere else. "  She stated her BP " runs high ", no meds. BP 130/92 at 1428. SPO2 97% P 74.   Hands less blotchy at 1433, face the same. mask irritating . " it didn't spread". Benadryl 25 mg po at 1438.  Hands much better, almost back to normal at 1450. She suspects it may be hand sanitizer; used at 2 points in building & touched face to adjust mask. left at 1455 w/ son.  RN, BSN.
ErythemaMultiform redness, itching, heat and swelling and injection site   Narrative: 1/6: redness, heat, swelling, itching at injection site- resolved 1/16: awoke to 7cm x 7cm swelling, redness, heat, itching - took benadryl; seems to be getting better 1/15
arm was sore; hard to move without pain; This is a spontaneous report from a contactable nurse. A patient of an unspecified age and gender received first dose of BNT162B2 (Pfizer/ BioNTech Covid-19 vaccine) in dominant arm on an unspecified date in Dec2020 (approximate 24 days ago) at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. Within hours that arm was sore and hard to move without pain. Patient could not get keys out of pocket without pain. Pain continued for 12 days. The outcome of the events was unknown. The patient received her second dose on 03Jan2021 in non dominant arm to avoid the lack of mobility.   Information about Lot/Batch has been requested.
Patient came into pharmacy 2 days after receiving the Fluad Quad injection.  Her arm below the injection site was red, hot and mildly swollen.  The area involved was down past the elbow.  She stated she had a horrible reaction the last time she had a flu shot.
Arm soreness; Diarrhea; Itching of scalp and limbs; Headache; tenderness and swelling at injection site; tenderness and swelling at injection site; This is a spontaneous report from a contactable nurse via Pfizer Sales Representative. A 62-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13) via an unspecified route of administration on an unspecified date at a single dose for immunization. Medical history included diabetes, blood pressure and cholesterol, all from an unknown date and unknown if ongoing. Concomitant medications include many medications (unspecified) for diabetes, blood pressure and cholesterol, all from an unknown date and unknown if ongoing. The patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) and reported the following adverse events the following day: diarrhea, itching of scalp and limbs, headache, tenderness and swelling at injection site as well as arm soreness. The patient had not recovered from the arm soreness at the time of reporting; while recovered for the rest of the events.  Information on the batch number has been requested.
This spontaneous report was received from a 55 year old female consumer referring on herself. Patient's pertinent medical history includes asthma and cancer. On 15-OCT-2014, the patient was vaccinated with a dose of PNEUMOVAX23 (lot # not reported). The patient stated that she used other unspecified medications (unspecified names, doses/frequencies and manufacturers). No lab diagnostics studies were performed. On 16-OCT-2014, the patient experienced swollen and painful lymph nodes, under the arm and on the collar bone, after receiving PNEUMOVAX23. The outcome of swollen and painful lymph nodes 23 was reported as not recovered/not resolved. The patient didn't seek medical attention and didn't receive any treatment for the adverse event. Additional information is not expected.
Vaccine administer 4:30 pm. Vomiting x 1 @ 10 pm.
fever; cough; body ache; nausea; This is a spontaneous report received from a contactable consumer or other non hcp. A 71-years-old female patient received 2nd dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE,Batch/Lot number was not reported), via an unspecified route of administration on 18Mar2021,at the age of 71 years old,as Dose 2, SINGLE for covid-19 immunization.The patient medical history and concomitant medications were not reported.The patient experienced fever, cough, body ache and nausea on Mar2021.The outcome of the event was unknown.Patient received no treatment for the adverse event.  No follow-up attempts are possible; information about lot/batch number cannot be obtained..
At 1:00 AM I started shivering and my teeth were chattering. This lasted until 3:30AM. In the morning I had a stomachache and was nauseous. At 3:30PM I felt really nauseous and started shivering again from 3:30PM until 7:30 PM. I was really tired and went to sleep. I felt a lot better in the morning but still had a little nausea. I just wanted to report it for your records. Thank you. Sleep was my only treatment.
Day after experienced body aches, head aches, and fever. Symptoms continued into  second day but more mild. Night of second day began to feel disoriented, trouble recalling performed tasks, and mood swings. Early morning of third day awakened by fever and odd heart beat. Third day milder symptoms of disorientation, mild hallucinations with lights, shadows, or objects moving. Along with a discomfort in upper abdomen. Continued mood swings.
Two weeks post vax pt had mild case of chickenpox, which consisted of 12 pox.
Patient is pregnant, in the first trimester 10 weeks. Patient states her OB-GYN recommended patient to get flu shot.
08/24/22 presents to ED for "Perc nephrostomy tube malfunction". PMHx of "CAD, hypothyroidism, diverticulosis, CKD stage IV, prostate cancer"
I received both of the Pfizer BioNtech vaccinations.  1 of 2 was given 1/13/2021 and 2of 2 given 2/10/2021.  I have had 2 healthy pregnancies and my husband has had 4 healthy pregnancies.  I received a positive pregnancy test 1/27/2022 and ended up with a blighted ovum and had to have a D&E on 2/24/2022.
Patient was given Covid 19 booster shot. A few minutes later, patient father came to pharmacy counter saying son not feeling well. Pharmacist went and checked on patient her was pale and not responding. Moved patient with fathers help to the ground. Patient was then awake. 911 was called and paramedics performed vital check. Patient father said he had experienced syncope before after flu vaccines.  Paramedics cleared patient to go after about 15 minutes.
ruined my health; This is a spontaneous report received from a non-contactable reporter (Consumer or other non0HCP), Program ID: (201253).  A 64-year-old male patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as DOSE 1, SINGLE (batch/lot number: unknown) for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: GENERAL PHYSICAL HEALTH DETERIORATION (non-serious), outcome "unknown" described as "ruined my health."  No follow-up attempts are possible; information about the batch/lot number cannot be obtained. No further information is expected.
chills, body aches, headache, fever, fatigue.   Began approximately 10 hours after vaccination. Progressed and became worse 10 to 12 hours after initial signs.  After about 8 hours of sleep side effects went away, except for headache which lasted approximately 4 more hours.   No medications were taken to treat reactions.
12/14/2007 Mother contacted clinic stating her daughter had swelling from shoulder to elbow, skin tight and warm to touch over swollen area. Patient c/o arm hurting. Mother stated she had received immunizations on 12/12/2007. Parent advised to bring pt in for assessment.
Presented for post vaccination check and reported numbness and tingling to wrist on arm of vaccination. This progressed to include the hand the following day.  01/24/2014 all symptoms have resolved.
Dose received: 3 / dose number = 3/ 37 year old female received Pfizer-BioNTech booster; Painful arm at injection site (Injection site pain).; This is a spontaneous report received from a non-contactable reporter (pharmacist). The reporter is the patient.  A 37-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in left arm, administration date 04Dec2021 at 09:15 (Lot number: FJ1620) at the age of 37 years, as dose 3 (booster), single for COVID-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: bnt162b2 (BNT162B2) DOSE 1, SINGLE; Lot number: EL6247; Anatomical location: Left arm, administration date 08Mar2021, when the patient was 36 years old, for COVID-19 immunisation; bnt162b2 (BNT162B2), DOSE 2, SINGLE; Lot number: EL6247; Anatomical location: Left arm, administration date 29Mar2021, when the patient was 36 years old, for COVID-19 immunisation.  The following information was reported: IMMUNISATION (non-serious) with onset 04Dec2021 at 09:15, outcome "unknown", described as "described as "Dose received: 3 / dose number = 3/ 37 year old female received Pfizer-BioNTech booster''; VACCINATION SITE PAIN (non-serious) with onset 04Dec2021, outcome "resolved" (05Dec2021), described as "painful arm at injection site (Injection site pain).'' Pain lasted for 24 hours. Therapeutic measures were not taken for the event injection site pain.   Additional Information. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  No follow-up attempts are possible. No further information is expected.
The day after ''my'' vaccine, about 30 hours after the shot, ''I'' began menstruating; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 15Apr2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune disorder and allergies to gluten. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included melatonin (MANUFACTURER UNKNOWN), collagen (MANUFACTURER UNKNOWN), curcuma longa rhizome (TURMERIC), Vitamin d nos (MANUFACTURER UNKNOWN) and sambucus nigra (ELDERBERRY); all for an unknown indication from an unknown date and unknown if ongoing. On 16Apr2021 at 20:00, the patient experienced not so much adverse as weird. The patient always began menstruation on or around the full moon. The day after her vaccine, about 30 hours after the shot, she began menstruating, had not stopped yet. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event about 30 hours after the shot, she began menstruating was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.     On 07-Jan-2021 at 4:27 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 07-Jan-2021 at 4:27 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 37.29  Concomitant products were not provided.   On 07-Jan-2021, Excursion time was 9A, 10A temperature was 34, 34 total doses given for the day was 96, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 05-Jan-2021, vial was moved to clinic on 07-Jan-2021. 18 vials were sent to clinic. Vaccine BUD date was 27-Jan-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Severe headache, severe muscle pain: neck, shoulders arms and upper back, chills. Injection site:  swelling, redness, heat, pain, (6" diameter redness). All symptoms (except injection site) resolved within approximately 12 hours. Treatment: ALEVE, TYLENOL Tension Headache.
Mother described small red bumps on arms, legs, body, and cheeks two hours post vax. No other symptoms. Advised to report to MD. Mother did not do this and states rash resolved in 2 days.
This case was reported by a physician via call center representative and described the occurrence of fever in a 2-month-old male patient who PEDIARIX. Concomitant products included Hib vaccine, PREVNAR 13 and Rotavirus vaccine. On24th October 2016, the patient received PEDIARIX. In October 2016, 2 days after receiving PEDIARIX, the patient experienced fever, irritability and rash. On an unknown date, the outcome of the fever was recovered/resolved and the outcome of the irritability and rash were unknown. It was unknown if the reporter considered the fever, irritability and rash to be related to PEDIARIX. Additional details were provided as follows: The patient went to the emergency room. The healthcare professional had no product information. The body temperature was recorded as 100.8 degree F. In October 2016, less than a week after receiving PEDIARIX, the patient experienced rash.
Fever, malaise, chills, muscle aches, extreme fatigue, cough, hives, generalized body edema, airway tightness, facial swelling.
c/o lower back aching, & leg muscles tighten;c/o spasms in lt arm, recv vax in rt arm;rt arm was sl sore, but improving;
Received vaccine and a few hours later, he started feeling fatigue, feverish, myalgias, and complained of L arm soreness and warmth to touch. He also noticed facial erythema and swelling that day as well.
bruising; discomfort; Darkening of skin around injection area; tenderness in shoulder; tenderness at injection site; This spontaneous report was received from a consumer referring to him/herself, a 51-year-old patient of unknown genre with hiv infection. The patient's medical history was not provided and had no drug allergies and concomitant medications.  On 20-JUL-2021, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), at a dose of 0.5 milliliter, intramuscular for pneumococcal disease prophylaxis (strength, anatomical site, vaccination schedule, lot# and expiration date were not provided).  On the same date, the patient experienced bruising (contusion), discomfort, darkening of skin around injection area (vaccination site discolouration) and tenderness in shoulder and injection site (arthralgia and vaccination site pain). No treatment was given for the reported events.  The reporter stated that he/she recovered from discomfort, vaccination site pain and arthralgia on 22-JUL-2021 (reported as within two days); in addition, It was reported that skin around injection site continues to remain dark (contusion and vaccination site discolouration) which was reported as recovering.  The causality assessment between the occurrence of the events and the suspect vaccine administration was not provided.  The reporter considered that the reported events were not life threatening or disabling.